Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP)
$0.30
+0.0016 ( +0.53% ) 143.6K
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Market Data
Open
$0.30
Previous close
$0.30
Volume
143.6K
Market cap
$11.22M
Day range
$0.30 - $0.31
52 week range
$0.23 - $1.41
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Jun 20, 2024 |
10-q | Quarterly Reports | 58 | May 10, 2024 |
10-k | Annual reports | 70 | Mar 26, 2024 |
10-k/a | Quarterly Reports | 57 | Mar 25, 2024 |
10-q/a | Quarterly Reports | 59 | Mar 25, 2024 |
10-q/a | Quarterly Reports | 57 | Mar 25, 2024 |
10-q/a | Quarterly Reports | 55 | Mar 25, 2024 |
8-k | 8K-related | 14 | Mar 25, 2024 |
8-k | 8K-related | 15 | Feb 01, 2024 |
3 | Insider transactions | 1 | Jan 17, 2024 |